Tolterodine

TERMINATED · PHASE2 · Overactive Bladder, Urinary Incontinence

side effect profile did not match expectations

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.